{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:49:33Z","timestamp":1787870973433,"version":"build-2784847793"},"reference-count":37,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The guidelines for chronic urticaria in children contain recommendations that are often based on adult studies. The diagnostic pathway has not been standardized and the effectiveness of anti-H1, omalizumab, montelukast, and systemic glucocorticoids is rarely reported in the pediatric population. There is a wide variation in the rate of remission of chronic urticaria between studies. The aim of this study is to enhance our understanding of pediatric chronic urticaria. Materials and Methods: This study enrolled 37 children with chronic urticaria aged from 0 to 18 years. Demographic parameters, medical history, clinical features, laboratory data and treatment information were collected. Children were treated with the recommended dosage of second-generation H1-antihistamines, which was increased by up to twofold. Omalizumab was added for refractory anti-H1 patients. A three-day course with systemic glucocorticoids was administered for severe exacerbations. Montelukast was administered to some children. Results: Wheals without angioedema were common. Chronic urticaria was spontaneous in 32 children (86.48%), inducible in 2 (5.41%), induced by a parasite in 1 and vasculitic in 2. Treatment of the potential causes of chronic urticaria was of no benefit, except for eradication of Dientamoeba fragilis. Chronic urticaria was resolved within three years in 45.9% of cases. Allergic diseases were present in nine children (24.32%) and autoimmune diseases were present in three (8.11%). All children were treated with anti-H1 at the licensed dose or at a higher dose. A partial or complete response to anti-H1 was observed in 29 (78.38%) patients. Montelukast showed no benefit. All children treated with omalizumab responded. Systemic glucocorticoids were successfully used to treat exacerbations. Conclusions: Our findings indicate that laboratory tests should not be routinely performed in children with chronic urticaria without clinical suspicion. However, comorbidities such as thyroid autoimmune disease and coeliac disease are suggested to be monitored over the chronic urticaria course. These clinical conditions could be diagnosed from the diagnostic framework of chronic urticaria. Increasing the dosage of anti-H1 and omalizumab was effective in children resistant to standard treatment but we still need further studies to generate a standard patient-centered treatment.<\/jats:p>","DOI":"10.3390\/medicina60050704","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T09:26:02Z","timestamp":1714123562000},"page":"704","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Characteristics, Investigations and Treatment in Children with Chronic Urticaria: An Observational Study"],"prefix":"10.3390","volume":"60","author":[{"given":"Enrico Vito","family":"Buono","sequence":"first","affiliation":[{"name":"Clinica Pediatrica, Azienda Ospedaliero-Universitaria, Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Giann\u00ec","sequence":"additional","affiliation":[{"name":"Clinica Pediatrica, Azienda Ospedaliero-Universitaria, Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Scavone","sequence":"additional","affiliation":[{"name":"Clinica Pediatrica, Azienda Ospedaliero-Universitaria, Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7710-6995","authenticated-orcid":false,"given":"Carlo","family":"Caffarelli","sequence":"additional","affiliation":[{"name":"Clinica Pediatrica, Azienda Ospedaliero-Universitaria, Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"Guideline for the Definition, Classification, Diagnosis and Management of Urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13052-019-0695-x","article-title":"Management of chronic urticaria in children: A clinical guideline","volume":"45","author":"Caffarelli","year":"2019","journal-title":"Ital. J. Pediatr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/all.12884","article-title":"The Definition, Diagnostic Testing, and Management of Chronic Inducible Urticarias\u2014The EAACI\/GA(2) LEN\/EDF\/UNEV. Consensus Recommendations 2016 Update and Revision","volume":"71","author":"Magerl","year":"2016","journal-title":"Allergy"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/adc.88.6.517","article-title":"Chronic urticaria: Association with thyroid autoimmunity","volume":"88","author":"Levy","year":"2003","journal-title":"Arch. Dis. Child."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1399-3038.2005.00309.x","article-title":"Chronic urticaria and associated coeliac disease in children: A case-control study","volume":"16","author":"Caminiti","year":"2005","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_6","first-page":"161","article-title":"Chronic urticaria in childhood: Natural course and etiology","volume":"51","author":"Harris","year":"1983","journal-title":"Ann. Allergy"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/jamadermatol.2017.3182","article-title":"Evaluating comorbidities, natural history, and predictors of early resolution in a cohort of children with chronic urticaria","volume":"153","author":"Netchiporouk","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref_8","first-page":"61","article-title":"Etiologic factors in childhood chronic urticaria","volume":"69","author":"Volonakis","year":"1992","journal-title":"Ann. Allergy"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1399-3038.2007.00667.x","article-title":"Clinical features and natural history of physical urticaria in children","volume":"19","author":"Khakoo","year":"2008","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.iac.2004.01.005","article-title":"Physical urticaria","volume":"24","author":"Dice","year":"2004","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1399-3038.2009.00912.x","article-title":"Identification of the etiologies of chronic urticaria in children: A prospective study of 94 patients","volume":"21","author":"Jirapongsananuruk","year":"2010","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1111\/bjd.15347","article-title":"Chronic urticaria and atopic disorders: A cross-sectional study of 11,271 patients","volume":"177","author":"Shalom","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archderm.134.12.1575","article-title":"The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema","volume":"134","author":"Kozel","year":"1998","journal-title":"Arch. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.anai.2013.07.031","article-title":"Contemporary approaches to the diagnosis and management of physical urticaria","volume":"111","author":"Lang","year":"2013","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.aller.2016.04.011","article-title":"The predictive factors for remission of chronic spontaneous urticaria in childhood: Outcome from a prospective study","volume":"44","author":"Eser","year":"2016","journal-title":"Allergol. Immunopathol."},{"key":"ref_16","first-page":"CD006137","article-title":"H1-Antihistamines for chronic spontaneous urticaria","volume":"2014","author":"Sharma","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2011.06.010","article-title":"a randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with h1-antihistamine-refractory chronic idiopathic urticaria","volume":"128","author":"Saini","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_19","first-page":"386","article-title":"usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: A retrospective analysis","volume":"20","author":"Asero","year":"2010","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2230.2006.02127.x","article-title":"Is there a role for antileukotrienes in urticaria?","volume":"31","author":"Pacor","year":"2006","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1365-2222.2004.02019.x","article-title":"desloratadine in combination with montelukast in the treatment of chronic urticaria: A randomized, double-blind, placebo-controlled study","volume":"34","author":"Nettis","year":"2004","journal-title":"Clin. Exp. Allergy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2133.1999.02707.x","article-title":"The autologous serum skin test: A screening test for autoantibodies in chronic idiopathic urticaria","volume":"140","author":"Sabroe","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"ref_23","first-page":"e15261","article-title":"An evaluation of the factors affecting the clinical and laboratory findings, prognosis, and treatment response in children with chronic urticaria","volume":"35","author":"Sancakli","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2222.1993.tb02480.x","article-title":"Elimination diet and intestinal permeability in atopic eczema: A preliminary study","volume":"23","author":"Caffarelli","year":"1993","journal-title":"Clin. Exp. Allergy"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00431-006-0410-y","article-title":"Characterization of irritable bowel syndrome and constipation in children with allergic diseases","volume":"166","author":"Caffarelli","year":"2007","journal-title":"Eur. J. Pediatr."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"\u00d6zhan, A.K., and Ar\u0131ko\u011flu, T. (2024). Evaluation of Pediatric Chronic Urticaria with Emphasis on Clinical and Laboratory Characteristics and Treatment Response to Omalizumab: A real-life experience from a tertiary allergy center. Children, 11.","DOI":"10.3390\/children11010086"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1542\/peds.113.4.e313","article-title":"Clinical features and anaphylaxis in children with cold urticaria","volume":"113","author":"Alangari","year":"2004","journal-title":"Pediatrics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2009.11.047","article-title":"The Effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria","volume":"125","author":"Staevska","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e13925","DOI":"10.1111\/pai.13925","article-title":"Differences between adult and pediatric chronic spontaneous urticaria from a cohort of 751 patients: Clinical features, associated conditions and indicators of treatment response","volume":"34","author":"Can","year":"2023","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jaad.2020.02.041","article-title":"Chronic urticaria in children can be controlled effectively with updosing second-generation antihistamines","volume":"82","author":"Gabrielli","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/pai.13325","article-title":"Efficacy and tolerability of the updosing of second-generation non-sedating H1 antihistamines in children with chronic spontaneous urticaria","volume":"32","author":"Sarti","year":"2021","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.anai.2017.02.003","article-title":"Clinical features of adolescents with chronic idiopathic or spontaneous urticaria: Review of omalizumab clinical trials","volume":"118","author":"Goldstein","year":"2017","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/pai.13426","article-title":"Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients","volume":"32","author":"Dekkers","year":"2021","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/all.14686","article-title":"Omalizumab in children and adolescents with chronic urticaria: A 16-week real-world study","volume":"76","author":"Song","year":"2021","journal-title":"Allergy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.aller.2020.03.011","article-title":"Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety","volume":"48","author":"Ocak","year":"2020","journal-title":"Allergol. Immunopathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/all.12056","article-title":"EAACI taskforce position paper: Evidence for autoimmune urticaria and proposal for defining diagnostic criteria","volume":"68","author":"Konstantinou","year":"2013","journal-title":"Allergy"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e13674","DOI":"10.1111\/pai.13674","article-title":"A European survey of management approaches in chronic urticaria in children: EAACI Pediatric Urticaria Taskforce","volume":"33","author":"Tsabouri","year":"2022","journal-title":"Pediatr. Allergy Immunol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/5\/704\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:33:48Z","timestamp":1760106828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/5\/704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["medicina60050704"],"URL":"https:\/\/doi.org\/10.3390\/medicina60050704","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]}}}